SLOT: Full Definition
What is semaglutide?
Semaglutide is a GLP-1 receptor agonist — a class of medications that mimics the natural gut hormone glucagon-like peptide-1. It is sold under three brand names: Ozempic (injectable, FDA-approved for type 2 diabetes), Wegovy (injectable, higher-dose, approved for weight loss), and Rybelsus (oral tablet for type 2 diabetes). All three contain the same active ingredient, just at different doses and in different delivery forms.
In women's health, semaglutide has become a major tool for weight loss, insulin resistance, PCOS-related metabolic dysfunction, and type 2 diabetes, with effects on appetite, blood sugar, and cardiovascular risk that go well beyond what diet alone has historically delivered.
How does semaglutide work?
GLP-1 is a hormone the gut releases after eating. It signals the pancreas to release insulin, slows stomach emptying, blunts appetite at the brain, and reduces glucagon (the hormone that raises blood sugar). Semaglutide binds to GLP-1 receptors and reproduces those effects with a much longer duration — once-weekly for the injectables, daily for oral.
The practical results: smaller portions feel satisfying, food noise quiets, snacking decreases, blood sugar stabilizes, and many patients lose 10 to 15% (or more) of body weight on Wegovy doses. Cardiovascular outcome trials have also shown reductions in heart attack, stroke, and cardiovascular death in patients with type 2 diabetes or established cardiovascular disease.
When is it prescribed?
Semaglutide is typically prescribed for:
- Type 2 diabetes inadequately controlled with diet and metformin.
- Weight loss in adults with BMI ≥ 30, or BMI ≥ 27 with at least one weight-related condition (Wegovy).
- Cardiovascular risk reduction in select patients.
- Increasingly, off-label for Insulin Resistance, [pcos], and metabolic dysfunction.
Patient considerations
The most common side effects are gastrointestinal — nausea, constipation, diarrhea, reflux, bloating, and early fullness. These are usually worst in the first weeks of titration and after dose increases. Less common but serious risks include pancreatitis, gallstones, and acute kidney injury (often from dehydration related to GI symptoms).
Semaglutide carries a black-box warning for thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), based on rodent data. It is not appropriate for patients with a personal or family history of medullary thyroid cancer or [multiple-endocrine-neoplasia-type-2] (MEN2). It should also be avoided in pregnancy and in patients with severe gastroparesis or a history of pancreatitis.
A critical issue we see clinically: muscle loss. Rapid weight loss on GLP-1s is roughly one-third lean mass, including muscle, unless patients deliberately protect it. That requires adequate protein (typically 1.2-1.6 g per kg of body weight per day) and regular resistance training. Without those two pieces, women lose strength, slow their metabolism, and risk regaining fat without the muscle to support a healthy resting energy expenditure.
At Modern Thyroid Clinic, we view semaglutide as one tool — not a strategy. The women who do best pair it with thyroid optimization, nutrient support, strength training, sleep, and a clear plan for what life looks like off the medication.
Common symptoms
Common questions
Is semaglutide safe if I have a thyroid condition?
Semaglutide carries a black-box warning specifically for medullary thyroid cancer and MEN2 syndrome — not for hypothyroidism, Hashimoto's, or routine thyroid nodules. Patients with Hashimoto's, hypothyroidism, or non-medullary thyroid history are generally considered candidates after individual evaluation. It is contraindicated if you or a close relative has had medullary thyroid carcinoma or MEN2. A baseline thyroid workup, neck exam, and clear family history conversation should happen before starting any GLP-1, and any new neck lumps or hoarseness should be reported promptly.
Will I lose muscle on semaglutide?
Yes, unless you actively protect it. Studies show that on GLP-1s, roughly one-third of weight lost is lean mass — including skeletal muscle. That matters because muscle drives resting metabolism, supports bone health, and protects long-term function. The two non-negotiable strategies are adequate protein (typically 1.2 to 1.6 grams per kilogram of body weight per day) and consistent resistance training at least two to three times per week. Without those, weight loss is fast but the body composition outcome is poor.
What happens when I stop semaglutide?
When semaglutide is stopped without a transition plan, appetite returns, food noise comes back, and most patients regain a substantial portion of the weight they lost — often the majority within a year. That isn't a personal failure; it reflects how the medication works on appetite biology. The right answer for many women is a plan that combines GLP-1 use with sustainable nutrition, strength training, thyroid optimization, sleep, and a long-term taper or maintenance dose strategy decided with a clinician — not abrupt stops.
Think you might be dealing with this?
Talk to a Modern Thyroid Clinic specialist about your symptoms, labs, and next steps.
Book a Discovery CallThis content is for educational purposes only and is not medical advice. Consult a licensed clinician for diagnosis and treatment. Content on this page does not create a doctor-patient relationship with Modern Thyroid Clinic.